Haleon guides for FY 2026 organic revenue growth of 3%-5% in pre-close brief
PUBT · 5d ago
Share
Listen to the news
- Haleon flagged FY 2026 organic revenue growth guidance of 3%-5%, with sequential improvement expected through the year.
- High-single-digit adjusted operating profit growth guidance at constant currency; net interest expense seen at about GBP 255 million.
- Q1 organic revenue growth was 2.2%, driven by price of 2.4% while volume/mix fell 0.2%.
- Category mix stayed uneven; Oral Health grew 8.3% while Respiratory Health fell 3.4% on a weak cold and flu season.
- H1 2026 results call set for July 30, 2026.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. HALEON plc published the original content used to generate this news brief on June 26, 2026, and is solely responsible for the information contained therein.
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.
Copyright © 2026 Webull. All Rights Reserved